This inventor holds 2 USPTO granted patents and 2 EPO patents. Top assignee: Forim-X Ag. Active years: 2013-2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013-2015
Title: Silke Grabherr: Innovator in Radiographic Contrast Agents
Introduction
Silke Grabherr is a prominent inventor based in Murten, Switzerland. She has made significant contributions to the field of medical imaging, particularly in the development of radiographic contrast agents. With a total of 2 patents, her work has advanced the methods used in angiography examinations.
Latest Patents
Silke Grabherr's latest patents focus on a radiographic contrast agent designed for postmortem, experimental, and diagnostic angiography. This innovative contrast agent is characterized by an essentially oil-based apolar contrast component suitable for X-ray examinations. The viscosity of this contrast component ranges from 30-100 mPas. The agent is unique in that it is formulated as a mixture with at least one additional apolar component, which has a viscosity that is less than or equal to that of the primary contrast component. The patents also disclose methods for angiography examinations utilizing this contrast agent, as well as applications for both polar and apolar contrast agents.
Career Highlights
Silke Grabherr is associated with Forim-X AG, where she continues to push the boundaries of innovation in medical imaging technology. Her work has been instrumental in enhancing the effectiveness of angiographic procedures, thereby improving diagnostic capabilities in medical settings.
Collaborations
Silke collaborates with Erich Gygax, contributing to the advancement of their shared goals in the field of medical imaging.
Conclusion
Silke Grabherr's contributions to the development of radiographic contrast agents have made a significant impact on the field of medical imaging. Her innovative approach and dedication to research continue to pave the way for advancements in diagnostic techniques.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile